FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
Links shared publicly online about this topic.
- 1,898total visits
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
fda.gov —
The U.S. Food and Drug Administration today said that it will require manufacturers of some immunosuppressant drugs used in kidney (renal) transplantation to update their labeling to reflect an increased risk of infections.
View full resource at fda.gov
Tags: Urinary System, Organ Transplantation, Kidney Transplant, Drug, FDA, Transplantation
Most Recently Shared on July 14, 2009 at 4:05 pm By:
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants http://bit.ly/40cOo
Labeling change for immunosuppressants used in kidney transplant rejection prophylaxis - MPR
empr.com — “The FDA is requiring manufacturers of some immunosuppressants used in the prevention of kidney transplant rejection to update their labeling to reflect an increased risk of infections.” View full resource at empr.com
Most Recently Shared on July 14, 2009 at 7:43 pm By:
MPR News: Labeling change for immunosuppressants used in kidney transplant rejection prophylaxis: The F.. http://tinyurl.com/lhylnm
Advertisement
